Lactobacillus bulgaricus inhibits colitis-associated cancer via a negative regulation of intestinal inflammation in azoxymethane/dextran sodium sulfate model

Figure 2 Lactobacillus bulgaricus attenuates intestinal inflammation in azoxymethene/dextran sulfate sodium-exposed mice. A: Relative body weight of azoxymethene/dextran sulfate sodium-induced mice treated or not with probiotic; B: Disease score determined by a scoring system based on clinical signs, such as weight loss, humid perianal region, presence of diarrhea, blood in the stool or perianal region, hyporreativity and piloerection; C: Colon length was determined using graduated images processed in ImageJ; D: Illustrative imagens of colon extension. Results are expressed as mean ± EPM. ^aP < 0.05, ^bP < 0.01, ^eP < 0.001 vs controls. Ctrl: Controls; Lb: Lactobacillus bulgaricus.